ASKA PHARMACEUTICAL HOLDINGS CO LTD financial statements, including revenue, expenses, profit, and loss
The total revenue of 4886 for the last quarter is 14.02 B JPY, and it's 18.38% lower compared to the previous quarter. The net income of Q4 23 is 1.09 B JPY.